Disc Medicine Inc [IRON] stock is trading at $70.75, up 0.67%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The IRON shares have gain 7.42% over the last week, with a monthly amount glided 18.03%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Disc Medicine Inc [NASDAQ: IRON] stock has seen the most recent analyst activity on July 21, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $86. TD Cowen started tracking the stock assigning a Buy rating. Morgan Stanley upgraded its rating to a Overweight but $85 remained the price target by the analyst firm on November 05, 2024. Raymond James upgraded its rating to Strong Buy for this stock on November 04, 2024, and upped its price target to $110. In a note dated October 23, 2024, Jefferies initiated an Buy rating and provided a target price of $89 on this stock.
Disc Medicine Inc [IRON] stock has fluctuated between $30.82 and $72.68 over the past year. Currently, Wall Street analysts expect the stock to reach $72.5 within the next 12 months. Disc Medicine Inc [NASDAQ: IRON] shares were valued at $70.75 at the most recent close of the market. An investor can expect a potential return of 2.47% based on the average IRON price forecast.
Analyzing the IRON fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -0.27 and Total Capital is -0.26. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 69.98 points at the first support level, and at 69.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 71.32, and for the 2nd resistance point, it is at 71.90.
Ratios To Look Out For
For context, Disc Medicine Inc’s Current Ratio is 32.11. In addition, the Quick Ratio stands at 32.11 and the Cash Ratio stands at 6.18.
Transactions by insiders
Recent insider trading involved Bitterman Kevin, Director, that happened on Oct 08 ’25 when 71961.0 shares were sold. Director, Bitterman Kevin completed a deal on Oct 07 ’25 to sell 18039.0 shares. Meanwhile, Shareholder Atlas Venture Opportunity Fund bought 71961.0 shares on Oct 08 ’25.
